Page 265 - Drug Class Review
P. 265

Drug Effectiveness Review Project

                                 Groups similar at baseline: N/A
                                    Alzheimer classification: NR
                                                                               Health Outcome Measures:   NR




                                        donepezil               72.9      58      NR   NR  Primary Outcome Measures: Adverse events noted during 6 months after first prescription for DON   Secondary Outcome Measures: NR  Timing of assessments: 6 months after first prescription for the drug    See adverse events (incidence > 5% reported)   Intermediate Outcome Measures:   Page 163 of 205













                                                                                  •         •














             Final Report Update 1     Authors: Dunn et al.   Year: 2000   POPULATION  CHARACTERISTICS:       Mean age (years):   Sex (% female):   Ethnicity:  Other germane population qualities:     OUTCOME ASSESSMENT:          RESULTS:     Alzheimer's Drugs
   260   261   262   263   264   265   266   267   268   269   270